Recent advances in genome sequencing technologies have made it more accessible and affordable. High-throughput sequencing methods, such as next-generation sequencing (NGS), have revolutionized the field by allowing rapid and precise sequencing of large numbers of genomes. These advances have facilitated the development of databases that correlate genetic variants with responses to toxicants, enhancing our ability to predict adverse outcomes.
